In the provision of our research services, we collaborate with the following groups:
- Genetic sequencing companies: once a company has provided diagnostic data about a specific disease-causing genetic mutation, we may partner with them to learn more about that specific mutation.
- Academic laboratories: as academia identifies more genes and their roles in disease, we partner with universities and contract research organizations to build a laboratory model of a patient’s specific genetic mutation. We then test a variety of approved drugs against that model and report our findings back to the patient’s physician.
- Pharmaceutical firms: when our research demonstrates that certain drugs provide benefits in our genetic models, we partner with pharma to repurpose these compounds for individuals with rare diseases.
By working together, we hope to provide information that can make a positive impact in patients’ lives.